Polycystic kidney disease trials in Belgium

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

  Where

  Gent, Leuven, Sint-Lambrechts-Woluwe

  Age

  28 days to 18 years

  People

  20 worldwide

  Run by

  Otsuka Pharmaceutical Development & Commercialization, Inc.

  See details and how to joinNCT04782258 · EU 2023-508218-41-00
• Phase 2Taking people
  ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  Where

  Leuven, Liège, Sint-Lambrechts-Woluwe

  Age

  18 years to 55 years

  People

  240 worldwide

  Run by

  Calico Life Sciences LLC

  See details and how to joinNCT06902558 · EU 2024-517143-31-00
• Phase 3Taking people
  HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

  Where

  Edegem, Leuven, Sint-Lambrechts-Woluwe

  Age

  18 years to 80 years

  People

  300 worldwide

  Run by

  University Medical Center Groningen

  See details and how to joinNCT05373264 · EU 2022-500210-26-00
• No phaseTaking people
  Somatosensory Phenotyping of ADPKD

  Where

  Leuven

  Age

  12 years and over

  People

  150

  Run by

  Universitaire Ziekenhuizen KU Leuven

  See details and how to joinNCT06970028